Food News and Research

RSS

Helix BioPharma's pre-IND meetings with the FDA for Topical Interferon Alpha-2b and L-DOS47 fruitful

Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").

7 Oct 2009

HHS and PEPFAR approve the 100th HIV/AIDS antiretroviral drug

The U.S. Department of Health and Human Services (HHS) today marked today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.

7 Oct 2009

Allsup: Disabled people experience difficulty in receiveing much-needed treatment

People with disabilities have crucial healthcare needs, but often experience difficulty in receiving much-needed treatment, according to Allsup, a nationwide provider of Social Security disability representation and Medicare services.

7 Oct 2009

Vaccination can lower the risks of allergy in children

Vaccination can lower children's risk of allergy. Cathleen Muche-Borowski and her coauthors present a clinical practice guideline for allergy prevention in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2009; 106[39]: 625-31).

7 Oct 2009

Magazine compiles rankings of U.S. nursing homes

U.S. News & World Report examines government data from more than 15,500 nursing homes to determine which are the nation's best: "At the core of the rankings is the data and ratings found on Nursing Home Compare, a federal website created by the Centers for Medicare and Medicaid Services.

7 Oct 2009

GTRI researchers to test the affect of RFID systems on implantable and wearable medical devices

Radio frequency identification (RFID) systems are widely used for applications that include inventory management, package tracking, toll collection, passport identification and airport luggage security. More recently, these systems have found their way into medical environments to track patients, equipment assets and staff members.

7 Oct 2009

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Idaho Technology, Inc. (ITI) has been granted Performance Tested Methods Status by the AOAC Research Institute (Certificate No. 100901) for its E.coli O157:H7 test used with the R.A.P.I.D.® LT Food Security System (FSS). The assay uses real-time PCR technology to identify the presence of E.coli O157:H7 in raw ground beef and uncooked spinach food samples.

7 Oct 2009

Get vaccinated against both H1N1 flu and the seasonal flu, advises Chief Nurse of the American Red Cross

With the first doses of the H1N1 (swine) flu vaccine being shipped and seasonal flu shots underway, people should be getting vaccinations when they can for these flu viruses, said Sharon Stanley, Chief Nurse of the American Red Cross.

7 Oct 2009

Health officials spray Indonesian city to prevent diseases; news outlets examine other natural disasters

News outlets explored the health implications of natural disasters in Indonesia, the Philippines, Tonga, Samoa and India:

7 Oct 2009

EnWave files a patent application for nutraREV equipment in Canada

EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.

7 Oct 2009

CryoValve SG aortic human heart valve receives Humanitarian Use Device designation

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug Administration (FDA) for its CryoValve® SG aortic human heart valve.

6 Oct 2009

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006.

6 Oct 2009

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.

6 Oct 2009

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

HeartWare International receives approval to expand its clinical sites

HeartWare International, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the number of clinical sites participating in its U.S. bridge-to-transplant trial, known as the ADVANCE trial.

6 Oct 2009

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications.

6 Oct 2009

OncoGenex' OGX-011 receives additional FDA Fast Track Designation for treating metastatic prostate cancer

OncoGenex Pharmaceuticals, Inc. announced today that OGX-011, also known as custirsen sodium, received an additional Fast Track Designation from the U.S. Food & Drug Administration (FDA) for progressive metastatic prostate cancer in combination with first-line docetaxel treatment.

6 Oct 2009

Pepsico's initiative to reduce obesity, joins HWCF

PepsiCo, Inc., one of the world's largest food and beverage companies, today announced that it will expand its existing efforts to help reduce obesity in the United States by joining the Healthy Weight Commitment Foundation (HWCF).

6 Oct 2009

Former HHS Secretary to be the featured speaker of the health care reform Webinar event

TogetherMD announced today Donna Shalala, President of the University of Miami and former Health and Human Services Secretary from 1993 - 2001, is the featured speaker for a candid discussion on health care reform in the United States. Ms. Shalala is well connected in Washington and with other critical stakeholders around the country. She will provide viewers with a unique view on health care reform in the United States.

6 Oct 2009

Food News and Research

Helix BioPharma's pre-IND meetings with the FDA for Topical Interferon Alpha-2b and L-DOS47 fruitful

HHS and PEPFAR approve the 100th HIV/AIDS antiretroviral drug

Allsup: Disabled people experience difficulty in receiveing much-needed treatment

Vaccination can lower the risks of allergy in children

Magazine compiles rankings of U.S. nursing homes

GTRI researchers to test the affect of RFID systems on implantable and wearable medical devices

AOAC Research Institute certifies Idaho's E.coli O157:H7 test

Get vaccinated against both H1N1 flu and the seasonal flu, advises Chief Nurse of the American Red Cross

Health officials spray Indonesian city to prevent diseases; news outlets examine other natural disasters

EnWave files a patent application for nutraREV equipment in Canada

CryoValve SG aortic human heart valve receives Humanitarian Use Device designation

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

Ground Zero Pharmaceuticals opens new office in Brisbane

HeartWare International receives approval to expand its clinical sites

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

OncoGenex' OGX-011 receives additional FDA Fast Track Designation for treating metastatic prostate cancer

Pepsico's initiative to reduce obesity, joins HWCF

Former HHS Secretary to be the featured speaker of the health care reform Webinar event

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News